Accurate measurement and monitoring of Intracranial Pressure (ICP) is essential for neurological patients in order to prevent ischemic and mechanical injury to the nervous system. Approximately, two-third of the population with severe head injury suffers from intracranial hypertension. In addition, men had higher death rates due to traumatic brain injury as compared to women.
ICP must be maintained at less than 15 mmHg for better management of head injuries, brain tumors, and hydrocephalus. The monitoring devices that are currently present for ICP measurement are either invasive or noninvasive in nature.
Global intracranial pressure monitoring devices market, by region, 2015
The ICP monitoring devices market includes invasive and noninvasive techniques. Invasive techniques comprise external ventricular drainage and microtransducer ICP monitoring. Growing prevalence of these neurological disorders on a global level is expected to play an important role in boosting the growth of the market.
External Ventricular Drainage (EVD) Technique
The EVD technique is a highly accurate ICP measurement tool that also provides therapeutic relief from elevated ICP with the help of cerebrospinal fluid drainage. Most of traumatic conditions, such as intracranial hemorrhage, traumatic brain injury, meningitis, and subarachnoid hemorrhage, are followed by raised ICP. These diseases benefit enormously from the EVD technique through continuous ICP monitoring and cerebrospinal fluid diversion. Therefore, these factors would propel the growth of EVD market during the forecast period.
EVD technique, however, is associated with few complications such as postoperative hemorrhage and bacterial colonization of the catheter. Hence, sterile practices must be performed in order to decrease the rate of infection in hospitals and emergency care centers.
Traumatic Brain Injury Applications
Intracranial hypertension is the most common complication in patients with traumatic brain injuries. Continuous monitoring of ICP in TBI patients has resulted in improved outcome as compared to other neurological examinations. TBI is majorly caused by falls, motor vehicle accidents, and assaults. According to the Centers for Disease Control and Prevention, from 2006 to 2010, falls were reported to account for 40% of all the TBIs in the U.S. Hence, these aforementioned factors are expected to drive the growth of TBI application in the global ICP monitoring devices market.
The ICP monitoring devices market is consolidated with only few of the companies taking the lead. However, the huge potential of the market is attracting a number of players to invest. Existing players are investing heavily in research and development to expand their product offerings to maintain a competitive advantage over others through the launch of technically advanced products. Some of the major players operating in the space include Medtronic plc; Integra LifeSciences Holdings Corporation; Codman & Shurtleff, Inc.; RAUMEDIC AG; Vittamed; Sophysa Ltd.; Orsan Medical Technologies; and Spiegelberg GmbH & Co. KG.
In-depth report on global intracranial pressure (ICP) monitoring devices market by Grand View Research:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.